The Australian High Court has dismissed a consumer product giant’s application to appeal an advertising judgement that found efficacy claims made by AFT Pharmaceuticals were justified.
In an announcement to the NZX this morning, AFT said it welcomed the dismissal of Reckitt & Benckiser’s
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
